By Dr Eva Stadler

Journal articles

Elias KM; Khan SR; Stadler E; Schlub TE; Cromer D; Polizzotto MN; Kent SJ; Turner T; Davenport MP; Khoury DS, 2024, 'Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis', The Lancet Microbe, 5, pp. e459 - e467, http://dx.doi.org/10.1016/S2666-5247(23)00398-1

Stadler E; Maiga M; Friedrich L; Thathy V; Demarta-Gatsi C; Dara A; Sogore F; Striepen J; Oeuvray C; Djimdé AA; Lee MCS; Dembélé L; Fidock DA; Khoury DS; Spangenberg T, 2023, 'Author Correction: Propensity of selecting mutant parasites for the antimalarial drug cabamiquine (Nature Communications, (2023), 14, 1, (5205), 10.1038/s41467-023-40974-8)', Nature Communications, 14, http://dx.doi.org/10.1038/s41467-023-41287-6

Stadler E; Cromer D; Ogunlade S; Ongoiba A; Doumbo S; Kayentao K; Traore B; Crompton PD; Portugal S; Davenport MP; Khoury DS, 2023, 'Evidence for exposure dependent carriage of malaria parasites across the dry season: modelling analysis of longitudinal data', Malaria Journal, 22, http://dx.doi.org/10.1186/s12936-023-04461-1

Stadler E; Burgess MT; Schlub TE; Khan SR; Chai KL; McQuilten ZK; Wood EM; Polizzotto MN; Kent SJ; Cromer D; Davenport MP; Khoury DS, 2023, 'Monoclonal antibody levels and protection from COVID-19', Nature Communications, 14, pp. 4545, http://dx.doi.org/10.1038/s41467-023-40204-1

Stadler E; Maiga M; Friedrich L; Thathy V; Demarta-Gatsi C; Dara A; Sogore F; Striepen J; Oeuvray C; Djimdé AA; Lee MCS; Dembélé L; Fidock DA; Khoury DS; Spangenberg T, 2023, 'Propensity of selecting mutant parasites for the antimalarial drug cabamiquine', Nature Communications, 14, http://dx.doi.org/10.1038/s41467-023-40974-8

Stadler E; Chai KL; Schlub TE; Cromer D; Khan SR; Polizzotto MN; Kent SJ; Beecher C; White H; Turner T; Skoetz N; Estcourt L; McQuilten ZK; Wood EM; Khoury DS; Davenport MP, 2023, 'Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis', The Lancet Microbe, 4, pp. e883 - e892, http://dx.doi.org/10.1016/S2666-5247(23)00194-5

Stadler E; Cromer D; Mehra S; Adekunle AI; Flegg JA; Anstey NM; Watson JA; Chu CS; Mueller I; Robinson LJ; Schlub TE; Davenport MP; Khoury DS, 2022, 'Population heterogeneity in Plasmodium vivax relapse risk', PLoS Neglected Tropical Diseases, 16, http://dx.doi.org/10.1371/journal.pntd.0010990

Koutsakos M; Lee WS; Reynaldi A; Tan HX; Gare G; Kinsella P; Liew KC; Taiaroa G; Williamson DA; Kent HE; Stadler E; Cromer D; Khoury DS; Wheatley AK; Juno JA; Davenport MP; Kent SJ, 2022, 'The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants', Immunity, 55, pp. 1316 - 1326.e4, http://dx.doi.org/10.1016/j.immuni.2022.05.018

Kent SJ; Khoury DS; Reynaldi A; Juno JA; Wheatley AK; Stadler E; John Wherry E; Triccas J; Sasson SC; Cromer D; Davenport MP, 2022, 'Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?', Nature Reviews Immunology, 22, pp. 387 - 397, http://dx.doi.org/10.1038/s41577-022-00716-1

Mehra S; Stadler E; Khoury D; McCaw JM; Flegg JA, 2022, 'Hypnozoite dynamics for Plasmodium vivax malaria: The epidemiological effects of radical cure', Journal of Theoretical Biology, 537, http://dx.doi.org/10.1016/j.jtbi.2022.111014

Stadler E; Müller J, 2020, 'Analyzing plasmid segregation: Existence and stability of the eigensolution in a non-compact case', Discrete and Continuous Dynamical Systems - Series B, 25, pp. 4127 - 4164, http://dx.doi.org/10.3934/dcdsb.2020090

Spriewald S; Stadler E; Hense BA; Münch PC; McHardy AC; Weiss AS; Obeng N; Müller J; Stecher B, 2020, 'Evolutionary stabilization of cooperative toxin production through a bacterium-plasmid-phage interplay', mBio, 11, pp. 1 - 18, http://dx.doi.org/10.1128/mBio.00912-20

Müller J; Spriewald S; Stecher B; Stadler E; Fuchs TM, 2019, 'Evolutionary Stability of Salmonella Competition with the Gut Microbiota: How the Environment Fosters Heterogeneity in Exploitative and Interference Competition', Journal of Molecular Biology, 431, pp. 4732 - 4748, http://dx.doi.org/10.1016/j.jmb.2019.06.027

Stadler E, 2019, 'Eigensolutions and spectral analysis of a model for vertical gene transfer of plasmids', Journal of Mathematical Biology, 78, pp. 1299 - 1330, http://dx.doi.org/10.1007/s00285-018-1310-2

Preprints

Elias K; Khan S; Stadler E; Schlub T; Cromer D; Polizzotto M; Kent S; Turner T; Davenport M; Khoury D, 2023, Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: A systematic review and meta-analysis, http://dx.doi.org/10.1101/2023.06.18.23291566

Stadler E; Cromer D; Ogunlade S; Ongoiba A; Doumbo S; Kayentao K; Traore B; Crompton P; Portugal S; Davenport M; Khoury D, 2022, A role for super-spreaders in carrying malaria parasites across the months-long dry season, http://dx.doi.org/10.1101/2022.04.28.22274398

Stadler E; Chai KL; Schlub T; Cromer D; Polizzotto M; Kent S; Beecher C; White H; White H; Turner T; Skoetz N; Skoetz N; Estcourt L; McQuilten Z; Wood E; Khoury D; Davenport M, 2022, Determinants of passive antibody efficacy in SARS-CoV-2 infection, http://dx.doi.org/10.1101/2022.03.21.22272672

Stadler E; Burgess M; Schlub T; Chai KL; McQuilten Z; Wood E; Polizzotto M; Kent S; Cromer D; Davenport M; Khoury D, 2022, Monoclonal antibody levels and protection from COVID-19, http://dx.doi.org/10.1101/2022.11.22.22282199

Stadler E; Cromer D; Mehra S; Adekunle A; Flegg J; Anstey N; Watson J; Chu C; Mueller I; Robinson L; Schlub T; Davenport M; Khoury D, 2022, Risk of Plasmodium vivax recurrences follows a 30-70 rule and indicates relapse heterogeneity in the population, http://dx.doi.org/10.1101/2022.05.18.22275180

Mehra S; Stadler E; Khoury D; McCaw JM; Flegg JA, 2021, Hypnozoite dynamics for Plasmodium vivax malaria: the epidemiological effects of radical cure, http://dx.doi.org/10.48550/arxiv.2107.00779

Koutsakos M; Lee WS; Reynaldi A; Tan H-X; Gare G; Kinsella P; Liew KC; Williamson D; Kent H; Stadler E; Cromer D; Khoury D; Wheatley A; Juno J; Davenport M; Kent S, 2021, Dynamics of immune recall following SARS-CoV-2 vaccination or breakthrough infection, http://dx.doi.org/10.1101/2021.12.23.21268285

Back to profile page